John R. Regan
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Computational Drug Discovery Methods, Synthesis and biological activity, Estrogen and related hormone effects, Hormonal Regulation and Hypertension
Most-Cited Works
- → Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site(2002)833 cited
- → Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate(2002)350 cited
- → The kinetics of binding to p38 MAP kinase by analogues of BIRB 796(2003)111 cited
- → Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)(2003)105 cited
- → The Non-Diaryl Heterocycle Classes of p38 MAP Kinase Inhibitors(2002)70 cited
- Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis.(2003)
- → Thermal Denaturation: A Method to Rank Slow Binding, High-Affinity P38α MAP Kinase Inhibitors(2003)45 cited
- → Quinol-4-ones as Steroid A-Ring Mimetics in Nonsteroidal Dissociated Glucocorticoid Agonists(2006)41 cited
- → RG 12561 (Dalvastatin): A Novel Synthetic Inhibitor of HMG-CoA Reductase and Cholesterol-Lowering Agent(1993)35 cited
- → Angiotensin converting enzyme inhibitors. 9. Novel [[N-(1-carboxyl-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activity(1990)24 cited